查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279846

2023-2030年全球抗酸剂市场规模研究与预测，按配方类型（片剂、粉剂、其他）、分销渠道（医院药店、电子商务、其他）和区域分析

Global Antacids Market Size study & Forecast, by Formulation Type (Tablet, Powder, Others) By Distribution Channel (Hospital Pharmacies, E-Commerce, Others) and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

抗酸剂是一种帮助减少胃酸和缓解胃酸过多相关症状的药物。这些非处方药的有效成分是碳酸氢钠、钙、镁或铝。它们的作用是与胃酸结合，产生中性化学物质，可以降低胃内容物的酸度。因此，抗酸剂可用于治疗包括消化不良、烧心和反酸等症状。抗酸剂经常被用来治疗胃酸过多带来的症状。它们有助于平衡导致胸部或胃部燃烧的酸。推动市场增长的关键因素是反酸和胃食管反流的流行率上升，OTC抗酸剂容易获得，以及老年人口对抗酸剂的需求上升，预计这将支持预测期间的市场增长。

此外，老年人口的增加是促进抗酸剂市场增长的因素之一。随着年龄的增长，他们更容易出现胃肠道问题，如反酸、烧心和胃食管反流病（GERD）。这些情况会引起胸部和喉咙的不适和疼痛，还可能导致其他健康并发症。因此，老年人口的增加预计将支持市场的增长。根据世界银行的数据，2015年，印度65岁及以上的人口数量为7461万，2021年该数字达到9575万。另外，根据同一来源，2016年，意大利65岁及以上人口占总人口的22%，2021年这一数字将达到24%。因此，该地区不断增长的老年人口预计将为市场创造一个有利可图的需求。此外，全球人口迅速变化的生活方式预计将在预测期内为市场创造有利可图的机会。然而，在2023-2030年的预测期内，抗酸剂市场上越来越多的替代品可能会扼杀市场增长。

全球抗酸剂市场研究考虑的主要地区包括亚太、北美、欧洲、拉美、中东和非洲。北美在2022年主导了市场，因为该地区有主要的市场参与者，有发达的医疗基础设施，心脏烧伤病例的增加，以及容易获得非处方药。在预测期内，亚太地区预计将大幅增长，因为诸如老年人口的增加、制药公司的增加、医疗开支的增加和人们对心脏烧伤认识的提高等因素预计将推动市场增长。

该研究的目的是确定近年来不同领域和国家的市场规模，并预测未来几年的价值。该报告旨在将研究涉及的国家内的行业的定性和定量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，并详细分析了竞争格局和主要参与者的产品。.

目录

第一章：执行摘要

  • 市场简介
  • 2020-2030年全球和细分市场的估计和预测
    • 2020-2030年抗酸剂市场，按地区划分
    • 2020-2030年，抗酸剂市场，按配方类型划分
    • 2020-2030年抗酸剂市场，按分销渠道划分
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球抗酸剂市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 行业演变
    • 研究的范围
  • 研究考虑的年份
  • 货币兑换率

第三章：全球抗酸剂市场动态

  • 抗酸剂市场影响分析（2020-2030年）
    • 市场驱动力
      • 胃酸倒流和胃食管反流病的发病率上升
      • 易于获得OTC抗酸剂
      • 老年人群对抗酸剂的需求上升
    • 市场挑战
      • 替代品的可用性
    • 市场机会
      • 全球人口快速变化的生活方式

第四章：全球抗酸剂市场行业分析

  • 波特的5力模型
    • 供应商的讨价还价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力影响分析
  • PEST分析
    • 政治
    • 经济
    • 社会
    • 技术
    • 环境
    • 法律问题
  • 最佳投资机会
  • 最佳策略
  • COVID-19影响分析
  • 颠覆性趋势
  • 行业专家的观点
  • 分析师建议和结论

第五章：全球抗酸剂市场，按配方类型划分

  • 市场简介
  • 按配方类型分類的全球抗酸剂市场，性能-潜力分析
  • 2020-2030年全球抗酸剂市场按配方类型的估计和预测
  • 抗酸剂市场，細項分析
    • 片剂
    • 粉剂
    • 其他类型

第六章：全球抗酸剂市场，按分销渠道划分

  • 市场简介
  • 按分销渠道分類的全球抗酸剂市场，表现 - 潜力分析
  • 2020-2030年全球抗酸剂市场按分销渠道的估计和预测
  • 抗酸剂市场，次级細項分析
    • 医院药店
    • 电子商务
    • 其他市场

第7章 ：全球抗酸剂市场，区域分析

  • 最领先的国家
  • 新兴国家
  • 抗酸剂市场，区域市场简介
  • 北美洲
    • 美国
      • 2020-2030年配方类型的细分估计和预测
      • 2020-2030年，分销渠道的细分估计和预测
    • 加拿大
  • 欧洲抗酸剂市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区抗酸剂市场简介
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲抗酸剂市场简介
    • 巴西
    • 墨西哥
  • 中东和非洲
    • 沙特阿拉伯
    • 南非
    • 中东和非洲其他地区

第八章：竞争情报

  • 主要公司SWOT分析
    • 公司1
    • 公司二
    • 公司3
  • 顶级市场战略
  • 公司简介
    • Abbott Laboratories
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • Alkem Laboratories Ltd.
    • Bayer AG
    • Cipla Ltd
    • Haleon plc
    • Infirst Healthcare Inc.
    • Pfizer Inc.
    • Prestige Consumer Healthcare Inc.
    • Reckitt Benckiser Group PLC,
    • WellSpring Pharmaceutical Corporation

第九章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Antacids Market is valued approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Antacid is a sort of medicine that aids to reduce stomach acid and alleviates symptoms associated to excess acid. These over-the-counter medications have sodium bicarbonate, calcium, magnesium, or aluminum as active ingredients. They function by combining with stomach acid to create neutral chemicals that can lessen the acidity of the stomach contents. Antacids can therefore be used to treat symptoms including indigestion, heartburn, and acid reflux. Antacids are frequently used to treat symptoms brought on by excessive stomach acid. They aid in balancing the acid that is responsible for the burning in the chest or stomach. The key factor driving the market growth is rising prevalence of acid reflux and GERD, easy availability of OTC antacids, and rise in the demand for antacids among geriatric population that anticipated to support the market growth during forecast period.

Moreover, the rising geriatric population is one of the factors contributing to the growth of the antacids market. As people age, they are more prone to developing gastrointestinal problems such as acid reflux, heartburn, and gastroesophageal reflux disease (GERD). These conditions can cause discomfort and pain in the chest and throat and can also lead to other health complications. Thus, the rising geriatric population is anticipated to support the market growth. According to The World Bank, in 2015, the number of people aged 65 and above in India was 74.61 million and the number reached 95.75 million in 2021. Also, according to the same source, in 2016, the 22% of total population ages 65 and above in Italy and the number is reached 24% in 2021. As a result, the rising geriatric population in the region is anticipated to create a lucrative demand for the market. Additionally, rapidly changing lifestyle of global population is anticipated to create the lucrative opportunity for the market during forecast period. However, the growing number of alternatives in the market for antacids may stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Antacids Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, availability of well-developed healthcare infrastructure, increase in incidences of heart burn cases, and easy availability of over-the-counter medication in this region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing presence of pharmaceutical companies, increase in healthcare expenditure and rise in awareness among people about heart burn are expected to drive market growth.

Major market players included in this report are:

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Bayer AG
  • Cipla Ltd
  • Haleon plc
  • Infirst Healthcare Inc.
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC,
  • WellSpring Pharmaceutical Corporation

Recent Developments in the Market:

  • In June 2022, Zydus Lifesciences received final approval from the United States Food and Drug Administration (FDA) to market Famotidine tablets in the strengths of 20 mg and 40 mg. Famotidine is a histamine H2 receptor blocker. It works by reducing the amount of acid in the stomach.

Global Antacids Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Formulation Type, Distribution Channel, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Formulation Type:

  • Tablet
  • Powder
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • E-Commerce
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Antacids Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Antacids Market, by Formulation Type, 2020-2030 (USD Billion)
    • 1.2.3. Antacids Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Antacids Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Antacids Market Dynamics

  • 3.1. Antacids Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of acid reflux and GERD
      • 3.1.1.2. Easy availability of OTC antacids
      • 3.1.1.3. Rise in the demand for antacids among geriatric population
    • 3.1.2. Market Challenges
      • 3.1.2.1. Availability of substitute
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rapidly changing lifestyle of global population

Chapter 4. Global Antacids Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Antacids Market, by Formulation Type

  • 5.1. Market Snapshot
  • 5.2. Global Antacids Market by Formulation Type, Performance - Potential Analysis
  • 5.3. Global Antacids Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
  • 5.4. Antacids Market, Sub Segment Analysis
    • 5.4.1. Tablet
    • 5.4.2. Powder
    • 5.4.3. Others

Chapter 6. Global Antacids Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Antacids Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Antacids Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 6.4. Antacids Market, Sub Segment Analysis
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. E-Commerce
    • 6.4.3. Others

Chapter 7. Global Antacids Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Antacids Market, Regional Market Snapshot
  • 7.4. North America Antacids Market
    • 7.4.1. U.S. Antacids Market
      • 7.4.1.1. Formulation Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Antacids Market
  • 7.5. Europe Antacids Market Snapshot
    • 7.5.1. U.K. Antacids Market
    • 7.5.2. Germany Antacids Market
    • 7.5.3. France Antacids Market
    • 7.5.4. Spain Antacids Market
    • 7.5.5. Italy Antacids Market
    • 7.5.6. Rest of Europe Antacids Market
  • 7.6. Asia-Pacific Antacids Market Snapshot
    • 7.6.1. China Antacids Market
    • 7.6.2. India Antacids Market
    • 7.6.3. Japan Antacids Market
    • 7.6.4. Australia Antacids Market
    • 7.6.5. South Korea Antacids Market
    • 7.6.6. Rest of Asia Pacific Antacids Market
  • 7.7. Latin America Antacids Market Snapshot
    • 7.7.1. Brazil Antacids Market
    • 7.7.2. Mexico Antacids Market
  • 7.8. Middle East & Africa Antacids Market
    • 7.8.1. Saudi Arabia Antacids Market
    • 7.8.2. South Africa Antacids Market
    • 7.8.3. Rest of Middle East & Africa Antacids Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Abbott Laboratories
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Alkem Laboratories Ltd.
    • 8.3.3. Bayer AG
    • 8.3.4. Cipla Ltd
    • 8.3.5. Haleon plc
    • 8.3.6. Infirst Healthcare Inc.
    • 8.3.7. Pfizer Inc.
    • 8.3.8. Prestige Consumer Healthcare Inc.
    • 8.3.9. Reckitt Benckiser Group PLC,
    • 8.3.10. WellSpring Pharmaceutical Corporation

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Antacids Market, report scope
  • TABLE 2. Global Antacids Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Antacids Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
  • TABLE 4. Global Antacids Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 5. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Antacids Market
  • TABLE 70. List of primary sources, used in the study of global Antacids Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Antacids Market, research methodology
  • FIG 2. Global Antacids Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Antacids Market, key trends 2022
  • FIG 5. Global Antacids Market, growth prospects 2023-2030
  • FIG 6. Global Antacids Market, porters 5 force model
  • FIG 7. Global Antacids Market, pest analysis
  • FIG 8. Global Antacids Market, value chain analysis
  • FIG 9. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Antacids Market, regional snapshot 2020 & 2030
  • FIG 15. North America Antacids Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Antacids Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Antacids Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Antacids Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Antacids Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable